3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
3
Lymphoid
2
Myeloid
1
Dermatologic
1
Conditions
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Neutropenia
1
Myeloproliferative Disorders
1
Interventions
liposomal amphotericin B
2
Cytarabine
2
lintuzumab
1
isavuconazole
1
Voriconazole
1
Vegetables
1
Moxifloxacin
1
Mitoxantrone
1
Mannose-Binding Lectin
1
Levofloxacin
1
Lenalidomide
1
Idarubicin
1
Filgrastim
1
Etoposide
1
Clofarabine
1
Ciprofloxacin
1
Cefepime
1
Caspofungin
1
Amoxicillin-Potassium Clavulanate Combination
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neutropenia
×
Levofloxacin
×
Myeloid
×
Clear all
NCT07528417
2026-04-22
MYELO-CAN:ABX
University of Manitoba
Phase 2
Not yet recruiting
75 enrolled